In Difficult Times For AAV Gene Therapies, AbbVie Boosts Regenxbio’s Ambitions

Wet AMD Is Challenging Target

 
• By Andrew McConaghie
  
Regenxbio
• Source: Alamy

More from Clinical Trials

More from R&D